virologist
long
known
viral
pathogenesi
must
studi
standpoint
viru
host
nevertheless
given
rel
simplic
studi
viru
alway
tractabl
outlin
previou
chapter
viruscentr
approach
yield
tremend
amount
inform
viral
genet
viral
replic
cycl
host
tissu
tropism
along
way
come
insight
host
innat
adapt
immun
respons
mani
way
virus
antagon
respons
exploit
cellular
process
advantag
last
decad
howev
new
opportun
studi
host
respons
emerg
nation
institut
health
depart
energi
announc
plan
map
sequenc
human
genom
eleven
year
later
first
draft
genom
releas
project
declar
complet
sequenc
human
genom
dramat
chang
field
viral
pathogenesi
virologist
abl
move
beyond
viruscentr
singlegen
approach
instead
investig
host
respons
infect
genomewid
scale
human
genom
sequenc
hand
becam
possibl
predict
complet
constel
human
gene
correspond
mrna
transcript
encod
protein
product
inform
spur
develop
method
measur
global
gene
express
protein
abund
turn
mandat
develop
comput
method
interpret
result
avalanch
data
sidebar
chapter
focu
insight
viral
pathogenesi
provid
examin
host
transcript
respons
includ
dynam
innat
acquir
immun
diagnost
signatur
identif
target
antivir
drug
also
touch
briefli
data
interpret
protein
metabolit
profil
although
method
use
measur
protein
metabolit
abund
ie
chromatographi
mass
spectrometri
differ
use
measur
gene
express
downstream
data
analysi
approach
similar
integr
gene
express
protein
metabolit
abund
data
bring
us
closer
true
system
level
understand
virushost
interact
use
largescal
genet
proteinprotein
interact
screen
identifi
host
protein
promot
inhibit
viral
surviv
subject
chapter
virushost
interactom
basic
level
profil
host
transcript
respons
viral
infect
entail
measur
chang
level
mrna
transcript
present
cell
popul
presenc
absenc
viru
inde
first
publish
applic
largescal
genom
profil
virolog
essenti
simpl
studi
examin
transcript
respons
primari
human
fibroblast
three
time
point
follow
infect
human
cytomegaloviru
zhu
et
al
yet
even
simpl
experiment
plan
monitor
express
approxim
gene
reveal
complex
host
respons
also
complex
data
interpret
chang
transcript
abund
due
chang
synthesi
stabil
degrad
chang
may
may
correspond
chang
protein
abund
activ
transcript
respons
depend
upon
time
cell
type
viru
paramet
even
today
biolog
function
mani
gene
unknown
number
transcript
profil
current
technolog
number
ten
thousand
comput
requir
data
analysi
consider
initi
studi
host
respons
human
cytomegaloviru
identifi
mrna
transcript
chang
factor
four
includ
transcript
encod
major
histocompat
complex
surfac
receptor
multipl
compon
pathway
produc
prostaglandin
inflammatori
mediat
author
conclud
global
analysi
chang
mrna
level
provid
catalog
gene
modul
result
hostpathogen
interact
therefor
deserv
scrutini
larg
extent
forwardlook
statement
also
sum
perhap
main
challeng
associ
genom
profil
global
analysi
transcript
produc
catalog
differenti
express
gene
oftentim
catalog
extrem
larg
investig
must
devis
strategi
sift
catalog
determin
gene
deserv
scrutini
ideal
genom
profil
also
produc
list
reveal
interrelationship
gene
structur
activ
gene
network
function
gene
role
previous
ascrib
also
mean
gain
pattern
within
data
describ
later
inform
use
predict
diagnost
purpos
comput
screen
new
antivir
drug
earliest
assay
largescal
transcript
profil
consist
cdna
oligonucleotid
spot
onto
sequenc
human
genom
advent
highthroughput
molecular
profil
wide
credit
give
rise
system
biolog
one
sens
may
true
converg
genom
sequenc
inform
profil
technolog
comput
advanc
made
possibl
examin
biolog
system
scale
never
possibl
howev
concept
underli
system
biolog
understand
need
comprehend
complet
system
deeper
root
notion
emerg
propertiesproperti
outcom
predict
understand
individu
part
system
aloned
back
least
time
aristotl
bc
state
whole
someth
part
sum
nevertheless
reductionismth
idea
complex
system
analyz
understood
reduc
manag
piecesheld
sway
much
modern
histori
earli
view
began
chang
becam
appar
exampl
biolog
system
hierarchi
organ
compon
system
behav
differ
isol
intact
system
trewava
first
known
use
term
system
biolog
propos
distinct
disciplin
attribut
mihajlo
mesarov
book
system
theori
biolog
system
biolog
met
skeptic
review
book
note
doubt
systemtheoret
idea
seem
somewhat
strang
perhap
littl
frighten
present
gener
structurallyori
biologist
rosen
current
concept
system
biologydriven
genomebas
technolog
mathematicsi
often
associ
leroy
hood
founder
institut
system
biolog
hood
propos
biolog
system
compos
two
type
inform
gene
network
regulatori
interact
biolog
view
inform
scienc
idek
et
al
view
studi
biolog
system
requir
detail
knowledg
compon
system
systemat
perturb
system
monitor
gene
protein
pathway
respons
formul
mathemat
model
describ
system
respons
perturb
viral
infect
exampl
perturb
today
system
biolog
becom
drive
forc
biolog
medicin
although
still
often
critic
focus
data
acquisit
put
nobel
laureat
sidney
brenner
everybodi
want
measur
everyth
never
get
anyth
critic
may
eventu
mute
howev
system
biolog
continu
evolv
driven
current
rapid
advanc
comput
mathemat
network
model
essenti
make
complex
system
comprehens
nitrocellulos
membran
first
array
sinc
replac
commerci
avail
platform
ten
thousand
oligonucleotid
array
high
densiti
glass
slide
solid
support
protein
microarray
proteinprotein
interact
profil
discuss
chapter
virushost
interactom
yet
even
wealth
inform
avail
use
microarray
compar
level
inform
obtain
direct
sequenc
rna
transcript
rnaseq
nextgener
sequenc
sequencingbysynthesi
approach
replac
firstgener
sanger
sequenc
method
capabl
yield
truli
comprehens
view
transcriptom
discuss
detail
section
chapter
sidebar
whether
gener
microarray
analysi
rnaseq
transcript
profil
pattern
gene
express
observ
biolog
system
often
comparison
made
normal
rest
state
one
time
point
follow
perturb
system
simpler
biolog
system
easier
manipul
gener
interpret
transcript
data
virolog
simpl
system
mean
infect
cultur
cell
cell
cultur
experi
facilit
rapid
examin
multipl
time
point
virus
use
examin
model
intracellular
signal
respons
infect
howev
limit
phenotyp
paramet
studi
use
cultur
cellsvir
replic
cytopath
effectmak
difficult
studi
viral
pathogenesi
contrast
anim
model
possibl
measur
varieti
diseas
parameterseg
viru
yield
clinic
sign
gross
patholog
histopatholog
time
recoveri
deathand
cell
tissu
examin
come
natur
environ
cours
benefit
balanc
cost
ethic
complex
anim
model
interpret
transcript
profil
associ
viral
infect
perturb
take
varieti
form
case
begin
comput
determin
gene
differenti
express
condit
time
point
statist
signific
degre
inform
alon
yield
import
scientif
insight
exampl
transcript
profil
interferontr
cultur
cell
tissu
whole
anim
use
defin
hundr
gene
induc
innat
immun
cytokin
mani
import
player
innat
antivir
respons
dna
microarray
trace
ancestri
southern
blot
genom
dna
digest
fragment
restrict
enzym
immobil
permeabl
membran
filter
subsequ
detect
label
dna
hybrid
southern
blot
gave
rise
revers
dot
blot
synthet
oligonucleotid
known
sequenc
call
probe
immobil
permeabl
membran
support
collect
dna
sequenc
analyz
call
target
label
appli
membran
hybrid
condit
use
permeabl
membran
howev
made
difficult
control
size
shape
spot
dna
limit
miniatur
limit
overcom
introduct
solid
support
provid
abil
accur
control
size
shape
locat
spot
robot
spot
cdna
onto
glass
slidesth
first
know
microarrayswa
pioneer
patrick
brown
stanford
univers
schena
et
al
interview
discov
magazin
brown
explain
appli
grant
develop
technolog
microarray
part
thoroughli
decid
would
make
one
anyway
importantli
use
solid
support
also
facilit
develop
method
situ
synthesi
nucleic
acid
surfac
use
approach
ink
jet
fabric
spot
droplet
nucleotid
reagent
instead
droplet
ink
photolithograph
method
similar
use
semiconductor
industri
today
major
commerci
provid
microarray
includ
affymetrix
agil
technolog
illumina
nimblegen
platform
vari
length
oligonucleotid
use
number
oligonucleotid
repres
gene
method
use
oligonucleotid
synthesi
attach
solid
support
microarray
technolog
also
adapt
profil
noncod
rna
express
dna
methyl
singl
nucleotid
polymorph
well
promot
analysi
detect
genomewid
dna
copi
number
variat
understand
interferoninduc
gene
express
hand
possibl
evalu
extent
viru
may
induc
interferon
signal
altern
encod
mechan
counteract
interferon
respons
similarli
transcript
profil
gene
knockout
cell
anim
use
evalu
role
specif
gene
host
respons
infect
studi
reveal
chang
gene
express
occur
result
gene
knockout
well
effect
knockout
host
respons
often
studi
also
reveal
exist
compensatori
signal
mechan
complic
data
interpret
slight
twist
approach
use
studi
interferoninduc
gene
confer
resist
influenza
viru
infect
lack
laboratori
strain
mice
anim
highli
suscept
mani
strain
influenza
viru
includ
reconstruct
pandem
viru
transcript
profil
lung
virusinfect
wildtyp
balbc
mice
lack
function
knockin
mice
carri
function
demonstr
profound
differ
gene
express
correl
reduc
mortal
mice
cilloniz
et
al
treatment
mice
interferon
prior
infect
increas
surviv
associ
increas
express
gene
relat
intercellular
signal
cellular
movement
decreas
express
inflammatori
cytokin
chemokin
gene
figur
transcript
profil
attach
rel
straightforward
studi
design
yield
inform
function
mediat
resist
influenza
viru
role
interferon
signal
process
exampl
differenti
express
gene
view
heat
map
rel
increas
decreas
gene
express
depict
use
color
gradat
gene
exhibit
similar
pattern
express
group
togeth
use
variou
cluster
algorithm
differenti
express
gene
identifi
import
know
biolog
biochem
function
encod
product
mani
gene
inform
obtain
varieti
public
eg
david
maintain
nation
institut
allergi
infecti
diseas
proprietari
eg
ingenu
pathway
analysi
databas
databas
bring
togeth
inform
individu
gene
multipl
sourc
includ
scientif
literatur
databas
david
exampl
includ
annot
categori
includ
gene
ontolog
proteinprotein
interact
protein
function
domain
diseas
associ
tissu
express
bioinformat
tool
use
sift
inform
deconstruct
larg
list
differenti
express
gene
function
relat
group
seen
exampl
group
gene
way
help
interpret
understand
biolog
inform
avail
highthroughput
data
import
keep
mind
howev
mani
gene
lack
function
annot
poorli
annot
mean
consider
inform
may
lost
data
analys
move
beyond
survey
gene
alreadi
known
function
fortun
one
broader
outcom
transcript
profil
studi
increas
function
annot
come
part
investig
use
network
model
approach
describ
later
piec
togeth
interact
common
express
pattern
link
variou
gene
use
infer
gene
function
evalu
transcript
profil
chang
time
provid
insight
time
magnitud
host
respons
impact
viral
pathogenesi
diseas
outcom
particularli
well
studi
case
influenza
viru
viru
renown
abil
continu
gener
new
variant
although
variant
caus
rel
mild
respiratori
diseas
other
caus
sever
even
fatal
infect
pandem
viru
exampl
caus
million
death
worldwid
make
respons
one
deadliest
infecti
diseas
outbreak
human
histori
sinc
late
highli
pathogen
avian
influenza
virus
caus
sporad
infect
human
popular
news
media
bird
flu
mortal
rate
estim
transcript
profil
lung
tissu
mice
macaqu
experiment
infect
highli
pathogen
influenza
virus
reveal
virus
elicit
rapid
induct
proinflammatori
cytokin
chemokin
gene
event
often
refer
cytokin
storm
gene
remain
highli
express
death
anim
contrast
anim
infect
lesspathogen
virus
exhibit
rapid
induct
interferon
innat
immun
respons
gene
respons
resolv
time
anim
recov
macaqu
viru
also
induc
disproportion
induct
gene
associ
inflammasom
group
gene
thought
part
protect
innat
immun
respons
influenza
virus
excess
activ
inflammasom
howev
appear
detriment
rather
protect
mice
highli
pathogen
avian
virus
also
downregul
antiinflammatori
gene
includ
respons
biogenesi
lipoxin
encod
suppressor
cytokin
signal
induc
lipoxin
control
inflammatori
respons
excess
sustain
inflammatori
respons
appear
promot
immunopatholog
innov
studi
use
autom
imag
analysi
gene
express
profil
flow
cytometri
shed
addit
insight
rel
contribut
direct
viral
damag
immunopatholog
lethal
influenza
viral
infect
brand
et
al
use
refer
topdown
system
analysi
approach
break
complex
system
finer
detail
transcript
profil
first
obtain
whole
lung
individu
immun
cell
popul
isol
lung
mice
infect
lethal
nonleth
influenza
viru
rather
focus
specif
gene
express
chang
transcript
data
organ
modul
consist
gene
coordin
pattern
express
figur
modul
gene
annot
highli
proinflammatori
uniqu
associ
lethal
infect
inflammatori
signatur
shown
larg
origin
neutrophil
rapidli
migrat
site
infect
poorli
contain
case
lethal
viru
author
suggest
initi
chemokinedriven
feedforward
pathway
first
neutrophil
scene
releas
chemokin
attract
addit
neutrophil
result
rapidli
escal
inflammatori
respons
tissu
damag
support
find
attenu
selfamplifi
process
experiment
reduct
elimin
neutrophil
number
increas
surviv
without
chang
viral
spread
altern
comput
methodolog
incorpor
geometr
represent
method
singular
valu
decompositionmultidimension
scale
use
visual
quantifi
kinet
host
transcript
respons
wildtyp
attenu
variant
highli
pathogen
avian
virus
approach
use
analyz
transcriptom
proteom
profil
deriv
lung
infect
mice
analysi
reveal
wildtyp
mutant
virus
elicit
differenti
express
mani
gene
magnitud
degre
gene
differenti
express
veloc
initi
host
respons
speed
chang
occur
best
correl
pathogen
outcom
transcript
profil
studi
also
shed
light
import
dynam
immun
activ
aid
come
primarili
studi
variou
nonhuman
primat
speci
infect
simian
immunodefici
viru
siv
natur
host
siv
sooti
mangabey
african
green
monkey
develop
aid
natur
experiment
infect
viru
contrast
asian
monkey
rhesu
pigtail
macaqu
develop
aid
follow
siv
infect
sever
independ
transcript
profil
studi
shown
natur
host
siv
exhibit
innat
immun
respons
viru
compar
exhibit
asian
macaqu
initi
level
viral
replic
also
compar
howev
natur
host
innat
immun
respons
limit
durat
wherea
macaqu
respons
sustain
figur
jacquelin
et
al
lead
chronic
immun
activ
associ
progress
aid
sivinfect
macaqu
hivinfect
individu
innat
antivir
respons
often
accompani
inflammatori
reaction
neg
regulatori
mechan
induct
necessari
return
antivir
respons
baselin
prevent
harm
effect
immun
activ
question
remain
natur
host
speci
abl
resolv
initi
respons
siv
wherea
macaqu
hivinfect
individu
one
hypothesi
propos
west
coast
model
immun
activ
suggest
kinet
activ
hold
key
beneck
et
al
west
coast
model
liken
viru
infect
wave
beach
immun
activ
mount
surf
board
mount
earli
late
bad
thing
happen
correct
model
import
implic
aid
vaccin
design
suggest
question
whether
adapt
immun
respons
mount
siv
hiv
could
irrelev
rather
may
benefici
devis
strategi
modul
time
durat
respons
prevent
chronic
immun
recognit
viru
addit
inform
kinet
hiv
siv
infect
lesson
learn
natur
host
speci
found
chapter
hiv
aid
concept
use
gene
express
profil
diagnost
purpos
first
propos
cancer
biolog
neutrophil
infiltr
larg
account
lethalityassoci
inflammatori
signatur
shown
princip
compon
analysi
sort
cell
microarray
base
gene
inflammatori
modul
amplitud
x
larg
depend
upon
whether
sampl
obtain
neutrophil
adapt
brand
et
al
permiss
discov
breast
tumor
transcript
profil
could
use
tumor
classif
differ
virus
elicit
differ
host
transcript
respons
might
also
expect
gene
express
profil
use
diagnost
purpos
make
predict
infect
therapeut
outcom
clinic
virolog
diagnost
test
reli
abil
detect
particular
viru
bloodstream
either
detect
viral
antigen
viral
genom
sequenc
contrast
host
genom
signatur
use
detect
unknown
well
known
virus
cancer
use
guid
choos
therapi
predictor
therapeut
diseas
outcom
sidebar
one
area
search
host
diagnost
marker
particularli
intens
hepat
virusinduc
liver
diseas
hepatocellular
carcinoma
liver
diseas
caus
hepat
c
viru
hcv
exampl
take
decad
develop
often
asymptomat
diseas
progress
cirrhosi
hepatocellular
carcinoma
point
transplant
may
remain
treatment
option
diagnosi
addit
hamper
lack
reliabl
noninvas
detect
method
altern
percutan
liver
biopsi
biomark
genom
profil
could
detect
blood
therefor
highli
desir
earli
diagnosi
liver
diseas
varieti
individu
candid
blood
biomark
identifi
aspart
alanin
aminotransferas
albumin
alkalin
phosphatas
biomark
provid
inform
liver
function
valu
sometim
normal
peopl
liver
diseas
damag
test
provid
inform
diseas
etiolog
unfortun
diagnost
genom
signatur
blood
hard
come
studi
therefor
focus
identif
marker
liver
tissu
although
profil
liver
gene
express
get
around
need
liver
biopsi
hope
genom
profil
predict
advanc
tissu
injuri
number
report
liver
gene
express
signatur
rang
half
dozen
sever
hundr
gene
may
prognost
hepatocellular
carcinoma
may
use
riskadjust
surveil
approach
hannivoort
et
al
progress
identifi
genom
marker
diagnosi
prognosi
hcvinduc
liver
diseas
hamper
length
time
infect
diseas
make
prospect
studi
difficult
group
patient
howev
time
period
compress
individu
receiv
liver
transplant
endstag
liver
diseas
caus
hcv
infect
transplant
liver
quickli
becom
infect
mani
transplant
recipi
show
biochem
histolog
evid
liver
injuri
first
year
transplant
approxim
onethird
develop
rapidli
progress
fibrosi
onset
cirrhosi
occur
littl
year
transplant
liver
transplant
recipi
therefor
repres
uniqu
studi
popul
discov
gene
express
chang
may
predict
diseas
progress
perhap
largest
studi
focus
popul
advanc
comput
approach
singular
valu
decompositionmultidimension
scale
use
analyz
transcript
data
obtain
serial
liver
biopsi
patient
rasmussen
et
al
studi
reveal
within
month
transplant
gene
differenti
express
progressor
develop
advers
clinic
outcom
year
transplant
mani
system
approach
use
virolog
pioneer
field
cancer
research
cancer
biologist
quick
embrac
system
biolog
way
understand
genet
epigenet
aberr
perturb
intracellular
signal
network
therebi
lead
carcinogenesi
system
approach
alreadi
yield
clinic
benefit
patient
exampl
give
rise
new
classif
scheme
breast
pancreat
cancer
turn
allow
clinician
identifi
patient
like
benefit
particular
therapi
cancer
research
field
aggress
develop
largescal
system
biolog
resourc
cancer
genom
atla
tcga
intern
cancer
genom
consortium
cancer
proteom
atla
field
also
drive
develop
new
mathemat
model
method
studi
relationship
intracellular
signal
behavior
cell
tissu
level
imag
cell
determin
spatial
orient
interact
environ
interplay
gene
express
pattern
tumor
behavior
mani
new
approach
doubt
make
way
virolog
research
note
howev
cancer
research
also
draw
virolog
good
exampl
use
dna
tumor
viru
protein
cancer
gene
discoveri
rozenblatt
rosen
et
al
studi
protein
four
type
tumor
virus
papillomaviru
epsteinbarr
viru
adenoviru
polyomaviru
test
abil
interact
human
gene
product
effect
express
individu
viral
gene
cell
cultur
also
assess
microarray
analysi
data
use
build
virushost
perturb
network
reveal
gene
pathway
commonli
affect
tumor
viru
protein
like
contribut
cancer
nonprogressor
includ
downregul
gene
associ
immun
inflammatori
respons
cell
cycl
progress
metabol
function
patient
progress
sever
liver
diseas
companion
studi
identifi
proteom
signatur
indic
oxid
stress
could
also
distinguish
progressor
nonprogressor
significantli
studi
show
transcript
proteom
marker
diseas
progress
detect
prior
histolog
evid
sever
liver
injuri
marker
may
therefor
eventu
basi
diagnost
test
identifi
patient
high
risk
diseas
progress
transplant
perhap
broadli
outsid
transplant
set
etiolog
diagnosi
respiratori
infect
challeng
moreov
mani
infect
caus
bacteri
pathogen
physician
often
treat
patient
antibiot
even
without
confirm
diagnosi
attempt
provid
speedi
resolut
symptom
therefor
import
develop
mean
rapidli
distinguish
viral
bacteri
infect
well
identifi
specif
etiolog
agent
even
though
respiratori
pathogen
typic
confin
respiratori
tract
grow
evid
differ
immun
cell
type
induc
gene
express
signatur
blood
may
use
accur
diagnos
acut
respiratori
viral
infect
initi
studi
aim
identifi
signatur
volunt
experiment
infect
rhinoviru
respiratori
syncyti
viru
influenza
viru
blood
sampl
taken
set
interv
follow
challeng
zaa
et
al
microarray
analysi
blood
gene
express
pattern
identifi
acut
respiratori
viral
signatur
common
symptomat
individu
three
viral
challeng
could
distinguish
symptomat
individu
uninfect
control
signatur
could
also
accur
distinguish
person
influenza
viru
infect
healthi
control
independ
communitybas
cohort
addit
use
analyz
publicli
avail
gene
express
data
blood
patient
bacteri
respiratori
infect
signatur
accur
distinguish
viral
bacteri
infect
recent
set
incorpor
revers
transcript
polymeras
chain
reaction
rtpcr
assay
zaa
et
al
rtpcr
establish
diagnost
platform
move
acut
respiratori
signatur
platform
repres
import
step
toward
eventu
clinic
use
assay
test
cohort
individu
arriv
emerg
room
fever
confirm
standard
microbiolog
assay
viral
bacteri
infect
rtpcr
assay
show
accuraci
distinguish
viral
bacteri
infect
suggest
measur
express
small
set
gene
blood
sampl
use
classifi
viral
respiratori
ill
realworld
set
figur
stage
therefor
set
use
patient
gene
express
signatur
viral
diagnost
prognost
howev
still
work
done
term
identifi
appropri
minim
set
signatur
assay
improv
specif
provid
diagnosi
specif
viral
agent
nevertheless
approach
provid
addit
complementari
inform
provid
microbiolog
assay
gene
express
profil
need
consid
substitut
current
diagnost
method
instead
combin
approach
like
yield
benefit
term
rapid
triag
evalu
febril
ill
without
clear
etiolog
understand
diseas
pathogenesi
unfortun
addit
scientif
challeng
use
genom
profil
clinic
set
face
increas
regulatori
hurdl
well
come
primarili
respons
use
faulti
possibl
fraudul
genom
marker
select
therapi
patient
enrol
clinic
trial
test
altern
chemotherapi
approach
treat
nonsmallcel
lung
cancer
kurzrock
et
al
aftermath
trial
institut
medicin
arm
nation
academi
scienc
provid
advic
polici
maker
recommend
diagnost
test
use
genom
data
view
devic
rather
laboratorybas
test
design
requir
genomicbas
diagnost
subject
addit
regulatori
control
overseen
food
drug
administr
fda
increas
regulatori
burden
like
result
increas
develop
cost
delay
test
implement
diagnost
prognost
develop
basi
gene
express
signatur
long
signatur
accur
predictor
necessarili
impart
insight
underli
mechan
viral
pathogenesi
though
often
similarli
examin
heat
map
function
annot
yield
consider
inform
host
respons
infect
use
largescal
transcript
inform
gain
insight
thing
work
molecular
level
identifi
regulatori
drug
target
necessari
organ
inform
differ
way
look
interrelationship
among
data
one
use
way
visual
relationship
form
biolog
network
network
built
use
gene
coexpress
direct
interact
encod
protein
share
regulatori
mechan
bind
transcript
factor
target
gene
biolog
network
typic
repres
graph
contain
node
gene
protein
line
refer
edg
connect
node
gene
coexpress
network
exampl
edg
determin
use
statist
measur
express
correl
result
network
analyz
use
variou
comput
method
link
network
topologyth
arrang
connect
compon
networkwith
biolog
properti
one
common
method
use
identifi
import
element
network
central
analysi
mani
concept
central
analysi
first
develop
analyz
social
network
inde
biolog
social
network
mani
similar
analyz
social
network
central
analysi
might
use
determin
influenti
person
network
analyz
biolog
network
type
analys
use
identifi
key
player
biolog
process
central
analysi
use
look
node
network
highli
interconnect
regul
restrict
flow
inform
biolog
network
gene
highli
interconnectedref
hubsar
often
function
import
similarli
gene
connect
bridg
multipl
subnetworksref
bottleneck
genesar
posit
play
power
role
regul
network
signal
even
though
may
fewer
connect
hub
gene
hub
bottleneck
gene
shown
significantli
like
essenti
microbi
virul
nonbottleneck
nonhub
counterpart
method
use
analyz
network
deriv
proteom
lipidom
profil
analysi
hcvinfect
hepatoma
cell
two
mitochondri
fatti
acid
oxid
enzym
dci
enoylcoa
delta
isomeras
hadhb
hydroxyacylcoa
thiolaseenoylcoa
hydratas
identifi
network
bottleneck
possibl
point
control
hcv
disrupt
cellular
metabol
homeostasi
figur
diamond
et
al
target
dci
knockdown
sirna
techniqu
subsequ
show
dci
requir
product
hcv
infect
cultur
cell
case
network
analysi
provid
inform
need
sort
larg
number
protein
focu
specif
target
scrutini
chang
fatti
acid
oxid
also
broadli
link
inflammatori
process
dendrit
cell
matur
regul
immun
respons
suggest
modul
fatti
acid
oxid
may
repres
target
antivir
therapi
understand
network
topolog
therefor
provid
opportun
identifi
potenti
host
target
therapeut
intervent
current
antivir
drug
direct
specif
viral
protein
target
drug
narrow
spectrum
mean
effect
specif
viru
vulner
emerg
viral
resist
mutat
viral
genom
moreov
medic
import
virus
small
genom
number
potenti
target
limit
contrast
treat
viral
infect
target
host
increas
number
target
decreas
likelihood
resist
virus
emerg
target
host
factor
may
also
increas
likelihood
drug
effect
wider
spectrum
viral
pathogen
analysi
coexpress
network
use
approach
central
analysi
one
way
identifi
potenti
host
target
dci
exampl
howev
combin
network
analysi
inform
proteinprotein
interact
data
may
improv
target
identif
demonstr
use
proteom
data
deriv
hcvinfect
hepatoma
cell
liver
tissu
obtain
hcvinfect
patient
mcdermott
et
al
proteinprotein
interact
data
eg
host
protein
known
interact
hcv
protein
integr
protein
coabund
network
network
topolog
analysi
integr
network
provid
improv
discrimin
bottleneck
hub
protein
similar
analysi
look
directli
host
factor
interact
hcvencod
protein
tripathi
et
al
interact
hcv
protein
host
factor
play
import
role
hcv
infect
includ
regul
viral
replic
product
viral
particl
interferon
resist
therefor
becom
attract
target
antivir
therapi
howev
rather
target
directli
may
possibl
target
one
host
factor
interact
identifi
host
target
protein
identifi
literatur
mine
use
yeast
twohybrid
approach
molecular
biolog
techniqu
use
discov
proteinprotein
interact
result
host
protein
use
build
interact
network
expand
incorpor
proteinprotein
interact
protein
target
result
protein
interact
topolog
analysi
use
identifi
bottleneck
hub
protein
intriguingli
analys
suggest
preferenti
interact
highli
central
protein
host
protein
interact
network
protein
function
varieti
cellular
process
includ
innat
immun
chemokin
signal
celltocel
commun
cellular
transport
among
bottleneck
protein
identifi
two
endoplasm
reticulum
protein
protein
present
low
densiti
lipoprotein
transport
vesicl
report
play
role
product
releas
infecti
hcv
cell
cultur
assay
knockdown
use
sirna
effect
viral
rna
level
significantli
reduc
viral
titer
regul
viral
propag
may
novel
target
antihcv
therapi
perhap
broadli
therapeut
target
virus
depend
upon
lipoprotein
vesicl
releas
infecti
viru
develop
new
drug
take
enorm
amount
time
averag
year
target
discoveri
fda
approv
failur
rate
cost
also
extraordinarili
high
even
target
identifi
valid
long
road
drug
develop
remain
one
strategi
reduc
time
expens
drug
develop
determin
whether
drug
approv
treat
one
diseas
might
repurpos
treat
anoth
similarli
mani
partial
develop
drug
candid
could
potenti
repurpos
new
indic
global
transcriptom
method
becom
central
drug
repurpos
effort
hurl
et
al
paradigm
find
way
antivir
drug
research
integr
network
surround
sever
key
bottleneck
identifi
comput
model
neighbor
bottleneck
integr
network
shown
relationship
protein
lipid
speci
gray
proteom
correl
purpl
lipidomicsproteom
correl
black
proteinprotein
interact
red
interact
viral
protein
lipid
speci
indic
yellow
diamond
hcv
protein
red
mitochondri
protein
squar
protein
involv
fatti
acid
black
adapt
diamond
et
al
permiss
invers
genom
signatur
approach
base
proposit
drug
therapeut
benefit
gener
gene
express
profil
invers
signatur
associ
diseas
figur
peng
et
al
approach
therefor
requir
knowledg
gene
express
profil
induc
larg
number
drug
inform
gener
connect
map
project
seek
find
connect
human
diseas
gene
express
profil
drug
action
connect
map
databas
contain
transcript
profil
gener
treat
cultur
human
cell
compound
mani
fdaapprov
drug
analyt
tool
use
calcul
connect
score
measur
similarityor
invers
similaritybetween
queri
gene
express
signatur
profil
databas
approach
first
use
identifi
drug
inhibit
influenza
viru
replic
common
express
signatur
identifi
cultur
human
lung
epitheli
cell
infect
differ
strain
human
avian
influenza
viru
gene
express
signatur
use
screen
drugassoci
profil
connect
map
databas
candid
antivir
identifi
invers
correl
common
signatur
eight
potenti
antivir
identifi
six
subsequ
determin
inhibit
influenza
viru
replic
includ
pandem
influenza
viru
use
gener
signatur
josset
et
al
use
genom
signatur
drug
screen
potenti
dramat
reduc
time
need
drug
develop
approach
may
particularli
benefici
appli
emerg
viral
infect
sever
recent
studi
use
approach
screen
drug
emerg
influenza
viru
strain
eg
virus
connect
map
also
use
identifi
drug
may
effect
middl
east
respiratori
syndrom
coronaviru
josset
et
al
studi
followup
valid
use
cell
cultur
demonstr
reduct
viral
replic
howev
remain
seen
whether
rapidli
drug
class
drug
identifi
method
actual
make
way
clinic
use
said
cancer
field
drug
repurpos
approach
use
connect
map
identifi
drug
candid
varieti
cancer
mani
drug
valid
cell
cultur
rodent
model
slow
move
clinic
trial
discuss
earlier
network
use
repres
regulatori
function
interact
gene
protein
combin
gene
protein
metabolit
one
goal
gener
network
identifi
target
antivir
drug
contrast
networkbas
drug
repurpos
strategi
aim
har
inform
contain
network
identifi
candid
drug
although
networkbas
approach
take
varieti
form
mani
focus
understand
diseas
connect
one
anotherthrough
similar
transcript
proteinprotein
interact
network
exampleor
peng
et
al
permiss
drug
connect
one
anoth
mechan
action
exampl
connect
map
also
use
construct
drug
network
identifi
connect
drug
basi
share
transcript
effect
case
differ
drug
rather
gene
protein
form
node
network
drug
also
connect
sideeffect
similar
use
infer
whether
two
drug
share
target
variou
networkstranscript
proteinprotein
interact
diseas
drugcan
also
integr
multilay
network
probe
drugdiseas
relationship
exampl
integr
analysi
gene
express
data
diseas
includ
sever
viral
diseas
human
proteinprotein
interact
data
yield
network
diseas
relationship
suthram
et
al
within
integr
network
set
common
pathway
identifi
mani
protein
pathway
found
target
exist
drug
identifi
diseas
relationship
share
drug
possibl
make
predict
repurpos
drug
one
diseas
anoth
everincreas
amount
genom
data
gener
infecti
diseas
research
networkbas
approach
sure
increasingli
exploit
repurpos
drug
fight
viral
infect
direct
sequenc
rna
transcript
yield
excit
new
view
transcript
landscap
stagger
amount
inform
avail
sequenc
exemplifi
encyclopedia
dna
element
encod
project
fund
nation
human
genom
research
institut
overal
goal
project
identifi
character
function
element
human
genom
includ
catalog
complet
repertoir
rna
produc
human
cell
project
reveal
much
three
quarter
human
genom
capabl
transcrib
cell
contain
mani
varieti
rna
transcript
djebali
et
al
includ
polyadenyl
nonpolyadenyl
transcript
known
unannot
proteincod
transcript
long
noncod
rna
nucleotid
intergen
transcript
small
noncod
rna
nucleotid
also
abund
includ
microrna
mirna
piwiinteract
rna
pirna
small
nuclear
rna
snrna
small
nucleolar
rna
snorna
transfer
rna
inde
transcript
landscap
complex
call
question
definit
gene
virologist
begin
explor
ramif
newfound
transcript
complex
viral
pathogenesi
one
first
studi
rnaseq
use
profil
host
respons
infect
sever
acut
respiratori
syndrom
coronaviru
sarscov
peng
et
al
lung
mice
infect
viru
noncod
rna
identifi
nearli
differenti
express
respons
infect
compar
express
profil
observ
cell
line
infect
influenza
viru
treat
type
interferon
suggest
rna
may
involv
innat
respons
varieti
virus
similar
analys
focus
sequenc
small
rna
reveal
sarscov
infect
also
induc
differenti
express
differ
class
small
noncod
rna
distinct
pattern
noncod
rna
express
observ
respons
mani
differ
rna
dna
virus
moreov
long
noncod
rna
limit
cellular
transcript
exampl
rnaseq
reveal
human
cytomegaloviru
hcmv
dna
viru
produc
hundr
previous
unidentifi
transcript
includ
altern
splice
transcript
long
noncod
rna
gather
et
al
hcmv
also
one
sever
virus
known
encod
mirna
rnaseq
reveal
hcmv
encod
addit
novel
form
small
rna
stark
et
al
even
viral
genom
capabl
produc
complex
transcript
profil
next
import
step
cours
determin
biolog
function
newli
found
long
noncod
rna
alreadi
evid
long
noncod
rna
play
role
transcript
epigenet
gene
regul
development
process
varieti
diseas
includ
neurolog
immun
disord
cancer
rna
may
function
direct
interact
specif
genom
sequenc
therebi
affect
chromatin
remodel
gene
transcript
transcript
factor
compon
transcript
machineri
exampl
long
noncod
rna
demonstr
interact
heterogen
nuclear
ribonucleoprotein
mediat
activ
repress
multipl
immun
respons
gene
carpent
et
al
similarli
report
neg
regul
interferon
respons
among
long
noncod
rna
induc
interferon
figur
kambara
et
al
knockdown
express
reduc
hcv
replic
interferontr
hepatocyt
upregul
liver
sampl
hcvinfect
patient
suggest
may
also
play
role
modul
interferon
respons
individu
unfortun
determin
biolog
function
long
noncod
rna
far
proven
challeng
unlik
protein
function
long
noncod
rna
present
predict
primari
sequenc
secondari
structur
thousand
rna
choos
difficult
know
pursu
exampl
chosen
studi
induct
respons
interferon
stimul
howev
long
noncod
rna
express
also
integr
network
model
may
help
provid
addit
inform
rna
focu
followup
studi
advent
new
genom
edit
techniqu
also
possibl
design
largescal
screen
identifi
long
noncod
rna
may
requir
viral
replic
virusinduc
cytopath
effect
detail
largescal
interact
screen
see
chapter
virushost
interactom
unquestion
rnaseq
discoveri
long
noncod
rna
usher
new
era
studi
viral
pathogenesi
essenti
gain
understand
role
rna
viral
infect
fulli
understand
mechan
virus
caus
diseas
also
like
better
understand
long
noncod
rna
function
lead
new
therapeut
option
rnabas
therapeuticsmost
focus
use
antisens
oligonucleotid
degrad
specif
mrnasar
alreadi
develop
inde
antivir
drug
fomivirsen
antisens
oligonucleotid
block
synthesi
key
cytomegaloviru
protein
first
drug
type
approv
fda
antisens
transcript
could
similarli
use
deplet
specif
long
noncod
rna
small
molecul
could
use
disrupt
interact
long
noncod
rna
protein
dna
partner
ongo
advanc
technolog
continu
spur
new
approach
studi
host
transcript
respons
viral
infect
current
studi
use
anim
model
still
examin
rna
profil
whole
tissu
becom
increasingli
common
augment
approach
analysi
isol
cell
popul
even
analysi
isol
cell
type
result
averag
transcriptom
million
cell
rnaseq
perform
singl
cell
therefor
emerg
new
frontier
transcript
profil
abil
perform
singlecel
analys
becom
possibl
improv
method
cell
isol
convers
miniscul
amount
cellular
rna
cdna
sequenc
although
singlecel
analys
necessari
appropri
type
studi
capabl
provid
uniqu
opportun
profil
celltocel
variabl
analys
reveal
surpris
variabl
express
hundr
immun
gene
across
singl
cell
well
variat
splice
pattern
shalek
et
al
effort
also
underway
incorpor
understand
epigenometh
herit
potenti
revers
genomewid
chemic
chang
dna
histon
protein
organismimpact
host
respons
viral
infect
epigenet
modif
dna
histon
methyl
result
chang
gene
express
alter
chromatin
structur
modif
occur
respons
multitud
environment
scatter
plot
depict
annot
lncrna
show
statist
signific
chang
fourfold
h
interferon
stimul
gray
dot
mark
lncrna
show
signific
chang
express
red
blue
dot
correspond
upregul
downregul
lncrna
respect
locat
neg
regul
interferon
respons
shown
adapt
kambara
et
al
permiss
chang
includ
viral
infect
addit
sever
virus
human
cytomegaloviru
epsteinbarr
viru
use
epigenet
mechan
part
switch
latent
activ
infect
ernberg
et
al
although
studi
involv
epigenet
mechan
viral
infect
still
infanc
studi
like
offer
new
clue
diseas
mechan
clearli
highthroughput
molecular
profil
reveal
host
respons
viral
infect
complic
ever
thought
possibl
moreov
gene
express
protein
abund
attend
regulatori
mechan
part
pictur
discuss
chapter
consider
must
also
given
proteinprotein
interact
host
metabol
host
genet
even
myriad
microorgan
form
human
microbiom
new
technolog
advanc
come
new
avalanch
data
field
argu
alreadi
suffer
inform
overload
perhap
need
improv
comput
method
integr
divers
type
data
identifi
new
interrelationship
includ
cooper
synergist
interact
may
arriv
form
new
geometr
approach
link
geometri
inform
theori
probabl
theori
law
et
al
meantim
even
complet
pictur
wait
assembl
plenti
discoveri
come
keep
virologist
energ
well
futur
